跳至主要内容
临床试验/NCT05095454
NCT05095454已完成不适用

A Pilot Study to Compare Short-Term Transcutaneous or Epidural Spinal Stimulation for Enabling Motor Function in Humans With Spinal Cord Injury

Kristin Zhao, PhD1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2022年3月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6
试验地点
1
主要终点
Transcranial Magnetic Stimulation Motor Evoked Potentials

研究概览

简要总结

A study comparing short-term delivery of epidural spinal stimulation versus transcutaneous spinal stimulation.

详细描述

The purpose of this study is to compare spinal motor nerve response to electrical stimulation delivered directly to the epidural space, and delivered through the skin (transcutaneously), and to measure any changes in motor performance over the course of about 5 months, during and after using one of the two types of stimulation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Spinal cord injury due to trauma located at or above the tenth thoracic vertebrae (T10)
  • •American Spinal Injury Association grading scale of A-D (2 from each) below the level of SCI
  • •Intact spinal reflexes below the level of SCI
  • •At least 1-year post-SCI
  • •At least 22 years of age
  • •Willing to use medically acceptable methods of contraception, if female and of child-bearing potential

排除标准

  • •Currently a prison inmate, or awaiting trial, related to criminal activity
  • •Pregnancy at the time of enrollment
  • •History of chronic and/or treatment resistant urinary tract infection
  • •Unhealed decubitus ulcer
  • •Unhealed skeletal fracture
  • •Untreated clinical diagnosis of depression
  • •Undergoing, or planning to undergo, diathermy treatment
  • •Active participation in another interventional clinical trial
  • •Presence of conditions or disorders which require MRI monitoring
  • •A history of coagulopathy or other significant cardiac or medical risk factors for surgery
  • •Current use of a ventilator
  • •Clinically diagnosed cardiopulmonary complications such as chronic obstructive pulmonary disease, cardiac failure, or heart arrhythmia that contraindicate changes in body position such as supine-to-sit-to-stand activities, prolonged standing, or stepping
  • •History of frequent hypotension characterized by light headedness, or loss of consciousness
  • •History of frequent hypertension characterized by headache, or bradycardia
  • •History of frequent, severe, autonomic dysreflexia
  • •Any illness or condition which, based on the research team's assessment, will compromise with the patient's ability to comply with the protocol, patient safety, or the validity of the data collected during this study.

研究组 & 干预措施

Percutaneous Epidural Stimulation

Experimental

Epidural spinal stimulation will be delivered via percutaneously implanted electrodes during rehabilitation. All implanted electrodes will be removed at the end of trial participation. The effects of epidural stimulation will be recorded via electrophysiological and biomechanical metrics described within the outcomes measures.

干预措施: Percutaneous epidural electrical spinal stimulation (Device)

Transcutaneous Epidural Stimulation

Experimental

Transcutaneous spinal stimulation will be delivered via skin surface-level electrodes during rehabilitation. The effects of transcutaneous stimulation will be recorded via electrophysiological and biomechanical metrics described within the outcomes measures.

干预措施: Transcutaneous electrical spinal stimulation (Device)

结局指标

主要结局

Transcranial Magnetic Stimulation Motor Evoked Potentials

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Measurement of the threshold percentage change in voltage between pre-intervention and post-intervention in the first trapezius or deltoid muscle activated.

Electromyography

时间窗: Through study completion; an average of 5 months.

Change in voltage measurements in major muscle groups below the level of injury. Specifically, change in soleus root mean square voltage during standing with and without stimulation.

Somatosensory Evoked Potentials

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Measurements of change in voltage in the conduction of electricity through the peripheral nerves, cervical and lumbosacral spinal cord, deep brain structures, and sensory cortex, using surface electrodes.

Foot Pressure

时间窗: Beginning of intervention to end of intervention, an average of 17 days.

Change in measurements of foot pressure in kilograms through shoe-insole pressure sensors.

Injury Severity: International Standards for Neurological Classification of Spinal Cord Injury

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Change sensory and motor function impairment using the American Spinal Injury Association Impairment Scale. Individuals are classified from A" (complete SCI) to "E" (normal function). 28 dermatomes and 10 key muscles are assessed bilaterally. Summed results produce overall sensory and motor scores and combine with evaluation of anal sensory and motor function in determination of AIS classification. Sensory scores are rated 0 (sensation absent) to 2 (normal), bilaterally for each of 28 dermatomes. Muscle function is rated 0 (total paralysis) to 5 (active movement, full range of motion against significant resistance) for each myotome. Upper Extremity Motor Subscores and Lower Extremity Motor Subscores are scored from 0 to 50; the ASIA Motor Score is scored from 0 to 100. The presence of deep anal pressure and voluntary anal contraction are assessed as a yes/no; absence of these, in addition to sensory scores of 0 at S4-5 indicate a Complete injury (otherwise, the injury is Incomplete).

Patient-reported Bowel Function

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Measurement of change in bowel function using the Neurogenic Bowel Dysfunction Score. Answers to qualitative questions are rated from 0 to 5, with a higher number indicating more problematic symptoms, and totaled for a score which categorizes severity of neurogenic bowel symptoms. The total score ranges between 0 and 44 points. A higher total score indicates more severe bowel symptoms.

Patient-reported Bladder Function

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Measurement of change in bladder function using the Neurogenic Bladder Symptom Score. Answers to qualitative questions are rated from 0 to 5, with a higher number indicating more problematic symptoms, and totaled for a score which categorizes severity of neurogenic bladder symptoms. The total score can range from 0 (no symptoms at all) to 74 (maximum symptoms).

Male Patient-reported Sexual Function (1)

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Measurement of change in erectile dysfunction using the Sexual Health Inventory for Men (SHIM). Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better erectile function, and totaled for a score which categorizes severity of erectile dysfunction. Total score can range from 1 to 25, with a lower number indicating more severe erectile dysfunction.

Male Patient-reported Sexual Function (2)

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Measurement of change in erectile dysfunction using the International Index for Erectile Function (IIEF). Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better erectile function, and totaled for a score which categorizes severity of erectile dysfunction. Total scores range from 5 to 25, with a lower score indicating more severe erectile dysfunction.

Female Patient-reported Sexual Function

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Measurement of change in sexual function using the Female Sexual Function Index (FSFI). Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better sexual function, and totaled for a score which categorizes severity of sexual dysfunction.

Spasticity

时间窗: Assessed at Baseline, 4 Weeks, 8 Weeks, and 20 Weeks; change from Baseline at week 20 reported.

Change in measurements of spasticity using the Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET). Answers to qualitative questions are rated from -3 to +3, with a higher positive number indicating more helpful symptoms, and a lower negative number indicating more problematic symptoms. Questions may also be answered as not applicable (N/A), which do not generate a score. Scores are totaled for a score which categorizes the overall positive or negative impact of a subject's spasticity symptoms. Total score can range from -105 (negative impact) to +105 (positive impact), and the score is averaged by total positive or negative score divided by the number of applicable answers.

Overground Ambulation [as Appropriate to the Subject]

时间窗: Baseline, 4 Weeks, 8 Weeks, and 20 Weeks

Measurement of changes in overground mobility as measured by the Modified 6 Minute Walk Test. Trainers will assess the distance in meters which the subject can cover in 6 minutes, with a greater distance characterizing better overground mobility.

Neurostimulation User Experience

时间窗: End of intervention, an average of 4 weeks

Rating of the subject's perception of individual aspects of spinal stimulation using the User Experience Questionnaire (UEQ), a survey including 26 descriptive terms and their antonyms. A scoring scale ranging from 1 to 7 determines how closely the subject feels the term or its antonym applies to the intervention, with lower numbers indicating agreement with the term, and higher numbers indicating agreement with the antonym. The terms and antonyms describe a positive and negative perception of each item. Subscales grouping terms into like categories average scores into a 7 point range from -3 to +3, with negative averages associated with negative perceptions, and positive averages associated with positive perceptions.

Trunk Stability

时间窗: Beginning of intervention to end of intervention, an average of 17 days, 8 weeks post beginning of intervention, 20 weeks post beginning of intervention; change from beginning of intervention at week 20 reported.

Changes in trunk stability based on stable forward reach measured in centimeters, with a greater distance of forward reach characterizing greater trunk stability. Specifically, change in forward reach at the end of the study when comparing stimulation assisted reach and non-stimulation assisted reach.

Neurostimulator Lead Location and Migration [Epidural Group Only]

时间窗: Pre-intervention and 4 weeks post-intervention

Evaluation of current array location via CT.

Bladder Function Testing

时间窗: Beginning of study, prior to initiating intervention; End of 4 weeks of intervention.

Change in measurements of bladder function (end fill detrusor value) utilizing a urodynamic test consisting of a filling phase and a voiding phase cystometrogram along with perineal patch muscle electromyography.

次要结局

未报告次要终点

研究者

发起方
Kristin Zhao, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kristin Zhao, PhD

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验